An open label, non randomized, clinical study to evaluate the efficacy and safety of homeopathic formulation of kidflame tablet in patient with kidney stones.

Bhargava Phytolab Limited0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•The Inclusion criteria are as follows (â??Yesâ?? to the following will allow the subjects to be included into study)
•1. Age: Adult-Above 18 years to 60 years, both male and female
•2. Willing to sign written inform consent
•3. Patients recently diagnosed with renal stone, the following signs and symptoms
•Pain in back radiating from back to groin
•Nausea and vomiting
•Frequent Urination
•Burning Micturition
•4. Confirmation of stone by USG KUB region- Measurable stone
•5. Non-complicated Kidney Stone(s) size over 3 mm to 18 mm

•The exclusion criteria are as follows (â??Yesâ?? to any one of the following will allow PI to exclude the subject from enrolling into the study
•1. Age: below 18 years to above 60 years,
•both male and female
•2. Not willing to sign written inform consent
•3.Size of single stone less than 3 mm
•4. Active urinary tract infection
•5. Complex stone anticipating multiple access site
•6. Stones that are not clearly able to be measured on USG-KUB
•7. Severe Hydronephrosis/ pylenephrosis
•8. Cystitis
•9. Patients with known history of DM and HTN
•10.H/o renal, hepatic or blood disorder or severe cardiac insufficiency
•11. Known history of hypersensitivity to herbal extracts or dietary supplements which is present in this formulation
•12. Subjects with ongoing fever
•13. Pregnant women, lactating women and women of child bearing potential not following adequate contraceptive measure, women who were found positive for urine pregnancy test

发起方

Bhargava Phytolab Limited